HOPPER PAUL
Transaction: 07/01/2028
OTHER
Change
+6,048,542
Price
$0.03
Filing
05/06/2026
Type
OTHER
Radiopharm Theranostics Limited
RADX • Biotechnology
$2.08
▼ -0.07 (-3.48%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$2.68M
Growth
126.8%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 126.8%Manageable debt level · 0Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 30, 2026, 12:08 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.08
Change-3.48%
Shares Out1.29M
Market Cap$2.68M
52W Range2.04 - 16.25
Beta0.80
P/E-1.15
P/S22.80
P/B2.50
P/FCF0.00
EV/Sales24.89
EV/EBITDA-1.01
Price$2.08
Change-3.48%
Shares Out1.29M
Market Cap$2.68M
52W Range2.04 - 16.25
Beta0.80
P/E-1.15
P/S22.80
P/B2.50
P/FCF0.00
EV/Sales24.89
EV/EBITDA-1.01
EV/FCF0.00
Earnings Yield-87.38%
FCF Yield0.00%
Dividend Yield0.00%
Gross Margin-77.67%
Oper. Margin-24.69%
Profit Margin-19.92%
Debt/Eq0.00
Current Ratio1.16
Quick Ratio1.16
Revenue 5Y126.79%
Target$6.00
Target Upside188.46%
Target Median$6.00
Target Range6.00 - 6.00
Volume333.27K
Avg Volume62.30K
EPS Surprise-0.74
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
51/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Positive revenue growth · 126.8%Manageable debt level · 0Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Price Target
2026-08-30
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00
Insider Transactions
Recent executive and insider activity
Voliotis Dimitris
Transaction: 07/01/2028
OTHER
Change
+7,657,334
Price
$0.03
Filing
05/06/2026
Type
OTHER
HOPPER PAUL
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
05/06/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| HOPPER PAUL | OTHER | +6,048,542 | $0.03 | 07/01/2028 | 05/06/2026 |
| Voliotis Dimitris | OTHER | +7,657,334 | $0.03 | 07/01/2028 | 05/06/2026 |
| HOPPER PAUL | OTHER | 0 | Not reported | 03/18/2026 | 05/06/2026 |
| HOPPER PAUL | OTHER | +1,403,723 | $0.17 | 07/01/2025 | 05/06/2026 |
| HOPPER PAUL | OTHER | +27,500,000 | $0.06 | 09/13/2024 | 05/06/2026 |
| HOPPER PAUL | OTHER | +3,571,428 | $0.20 | 11/25/2022 | 05/06/2026 |
| Laurita Aaron James | OTHER | 0 | Not reported | 03/18/2026 | 04/30/2026 |
| Laurita Aaron James | OTHER | +17,857 | $0.20 | 11/25/2022 | 04/30/2026 |
| Turner Ian Lawrence | OTHER | +483,768 | $0.11 | 03/18/2026 | 04/01/2026 |
| Turner Ian Lawrence | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| Donnelly Noel | OTHER | +5,333,333 | $0.06 | 03/18/2026 | 04/01/2026 |
| Turner Ian Lawrence | OTHER | +550,614 | $0.17 | 07/01/2025 | 04/01/2026 |
| Turner Ian Lawrence | OTHER | +750,000 | $0.06 | 09/12/2024 | 04/01/2026 |
| Turner Ian Lawrence | OTHER | +70,422 | $0.20 | 11/25/2022 | 04/01/2026 |
| Larkin Hester Denise | OTHER | +5,333,333 | $0.06 | 03/18/2026 | 03/31/2026 |
| Larkin Hester Denise | OTHER | 0 | Not reported | 03/18/2026 | 03/31/2026 |
| Canevari Riccardo | OTHER | +74,338,000 | $0.03 | 03/18/2026 | 03/31/2026 |
| Canevari Riccardo | OTHER | 0 | Not reported | 03/18/2026 | 03/31/2026 |
| Canevari Riccardo | OTHER | +4,167,946 | $0.17 | 07/01/2025 | 03/31/2026 |
| Larkin Hester Denise | OTHER | +627,000 | $0.60 | 11/16/2024 | 03/31/2026 |